| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/17/2005 | CA2537976A1 Ozonation products of cholesterol for the treatment and prevention of artherosclerosis and/or cardiovascular diseases |
| 03/17/2005 | CA2537953A1 Lentivirus vector-based approaches for generating an immune response to hiv in humans |
| 03/17/2005 | CA2537765A1 Methods and compositions for the prevention and treatment of genitourinary disorders, including pre-term labor and leiomyomas |
| 03/17/2005 | CA2537371A1 Antigenic peptides of rabies virus and uses thereof |
| 03/17/2005 | CA2537290A1 Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
| 03/17/2005 | CA2536669A1 Methods for intradermal delivery of therapeutics agents |
| 03/17/2005 | CA2536512A1 Rage-related methods and compositions for treating glomerular injury |
| 03/17/2005 | CA2535895A1 Anti-cd20 therapy of ocular disorders |
| 03/17/2005 | CA2535734A1 Composition for the prevention/treatment of hbv infections and hbv-mediated diseases |
| 03/17/2005 | CA2534907A1 Homogeneous preparations of il-28 and il-29 |
| 03/17/2005 | CA2534886A1 A method selecting an immunotherapeutic preparation |
| 03/17/2005 | CA2526398A1 Human monoclonal antibodies against bacillus anthracis protective antigen |
| 03/17/2005 | CA2517264A1 Ebola peptides and immunogenic compositions containing same |
| 03/16/2005 | EP1514937A1 Production of vaccines |
| 03/16/2005 | EP1514934A2 Biosynthetic binding protein for cancer marker |
| 03/16/2005 | EP1514876A2 Antibody against prostate stem cell antigen (PSCA) |
| 03/16/2005 | EP1514556A1 Botulinum toxin pharmaceutical compositions |
| 03/16/2005 | EP1514120A2 Mhc class ii haplotype specific immunodominancy of peptides derived from rsv fusion (f) and attachement (g) proteins |
| 03/16/2005 | EP1514104A1 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species |
| 03/16/2005 | EP1513959A2 Antiviral inhibitions of capsid proteins |
| 03/16/2005 | EP1513924A1 Attenuated listeria spp. and methods for using the same |
| 03/16/2005 | EP1513872A1 INFECTIOUS cDNA OF AN APPROVED VACCINE STRAIN OF MEASLES VIRUS, USE FOR IMMUNOGENIC COMPOSITIONS |
| 03/16/2005 | EP1513867A2 Extracellular junctional adhesion molecules |
| 03/16/2005 | EP1513864A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/16/2005 | EP1513554A1 Cd16a binding proteins and use for the treatment of immune disorders |
| 03/16/2005 | EP1513553A1 Methods and materials for treating inflammatory conditions |
| 03/16/2005 | EP1513552A1 Packaged virus-like particles for use as adjuvants: method of preparation and use |
| 03/16/2005 | EP1513551A1 Vaccination with immuno-isolated cells producing an immunomodulator |
| 03/16/2005 | EP1513550A2 Novel bacterium for treatment of disease |
| 03/16/2005 | EP1513549A2 Human prolactin antagonist-angiogenesis inhibitor fusion proteins |
| 03/16/2005 | EP1268784B1 Genes involved in intestinal inflammatory diseases and use thereof |
| 03/16/2005 | EP1226119B1 Tyrosine kinase inhibitors |
| 03/16/2005 | EP1204423B1 Therapeutic antibody against muc-1 antigen and methods for their use |
| 03/16/2005 | EP1165134B1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers |
| 03/16/2005 | EP1105495B1 Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
| 03/16/2005 | EP1024826B1 Passive immunization against clostridium difficile disease |
| 03/16/2005 | EP0948609B1 Llg polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 03/16/2005 | EP0918865B1 Immunologically active proteins of borrelia burgdorferi, coded nuclein acids of such and their use in test kits and vaccines |
| 03/16/2005 | EP0774964B1 Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 03/16/2005 | CN1596371A Novel self-assembly molecules |
| 03/16/2005 | CN1596313A Humanized collagen antibodies and related methods |
| 03/16/2005 | CN1596311A Mammalian cell-infecting virus vector encoding epitope-bound beta2m and utilization thereof |
| 03/16/2005 | CN1596309A Recombinant DNA encoding the major allergen of plantago lanceolata pollen, PLA L 1, and applications thereof |
| 03/16/2005 | CN1596269A A novel G protein-coupled receptor, gave 10 |
| 03/16/2005 | CN1596126A 疫苗 Vaccine |
| 03/16/2005 | CN1596117A Pine cone extracts and uses thereof |
| 03/16/2005 | CN1594362A Yolk antibody specific for helicobacter pylori and its preparation and application |
| 03/16/2005 | CN1594361A Human source anti- tetanus exotoxin antibody and preparation method and use thereof |
| 03/16/2005 | CN1594359A Hepatitis B vaccine and its preparation method |
| 03/16/2005 | CN1594348A T cell receptor sequence and method for detecting and treating rheumatoid arthritis |
| 03/16/2005 | CN1593662A Target directional confluent DNA vaccine for preventing caries and preparation method thereof |
| 03/16/2005 | CN1593659A Coupled compound of 5-methyl-morpholine-3-amino-2-oxazolidinone and preparation method thereof |
| 03/16/2005 | CN1593658A Coupled compound of 3-amino-2-oxazolidinone and preparation method thereof |
| 03/16/2005 | CN1593657A Production method of freeze dried chickenpox attenuated live vaccine and products therefrom |
| 03/16/2005 | CN1593169A Specific anti-helicobacter pylori immunological cow foremilk preparation method and its uses |
| 03/16/2005 | CN1193094C Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 03/16/2005 | CN1192799C Adjuvant combination formulations |
| 03/16/2005 | CN1192798C Vaccine |
| 03/16/2005 | CN1192797C Combination vaccine against streptocouus pneumoniae and respiratory syncytial virus (RSV) |
| 03/16/2005 | CN1192796C Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
| 03/15/2005 | US6867353 Production method of recombinant rotavirus structural proteins and vaccine composition |
| 03/15/2005 | US6867033 By administration of PV virus-like particles (VLPs) to a patient suffering from the PV infection |
| 03/15/2005 | US6867016 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 03/15/2005 | US6867007 Binary or polynary targeting and uses thereof |
| 03/15/2005 | US6867000 Method of enhancing immune responses to herpes |
| 03/15/2005 | US6866875 Pine cone extracts and uses thereof |
| 03/15/2005 | US6866855 Protein for use in the treatment and prevention of bacterial infections |
| 03/15/2005 | US6866853 Engineering live attenuated viruses which contain a modified nonstructural gene segment; influenza vaccines |
| 03/15/2005 | US6866852 Expression vector coding genetically engineered F protein of newcastle disease virus for developing poultry vaccine |
| 03/15/2005 | US6866850 Prevention and treatment of amyloidogenic disease |
| 03/15/2005 | US6866849 Administering an A beta peptide to induce immune response; monitoring and detecting antibodies having A beta binding specificity; Alzheimer*s disease |
| 03/15/2005 | US6866848 Diagnosis and therapy of immune disorders induced by inhibitors of blood-coagulation factor VIII and inhibitors to binding of von Willebrand factor and/or membrane phosphatides |
| 03/15/2005 | US6866847 Spraying live avirulent derivative of enteropathogenic bacterium comprising recombinant gene coding for protein expression; respiratory system disorder treatment in birds |
| 03/15/2005 | US6866846 Extracting body fluid containing immune complexes relevant to immunopathological condition; complexing with adsorbent; elution; fractionating, immobilization onto biocompatible carriers activated to bond to its surface |
| 03/15/2005 | US6866845 Administering anti-C5a antibodies to treat blood and toxin disorders |
| 03/15/2005 | US6866843 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell |
| 03/15/2005 | CA2170034C Recombinant humanized anti-human immunodeficiency virus antibody |
| 03/15/2005 | CA2124964C Cdw52-specific antibody for treatment of multiple sclerosis |
| 03/15/2005 | CA1341476C Moleculary cloned acquired immunodeficiency syndrome polypeptides and their methods of use |
| 03/10/2005 | WO2005022157A1 Evaluation of adjuvanted vaccines |
| 03/10/2005 | WO2005021789A1 Polypeptides involved in fungal biofilm formation and polynucleotides encoding same and uses thereof |
| 03/10/2005 | WO2005021754A1 Gp131: methods and compositions for treating cancer |
| 03/10/2005 | WO2005021734A2 Generation of hematopoietic chimerism and induction of central tolerance |
| 03/10/2005 | WO2005021730A2 Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells |
| 03/10/2005 | WO2005021726A2 Immunogenic hiv compositions and related methods |
| 03/10/2005 | WO2005021713A2 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
| 03/10/2005 | WO2005021707A2 Severe acute respiratory syndrome dna vaccine compositions and methods of use |
| 03/10/2005 | WO2005021592A2 Enhancing the circulating half-life of interleukin-2 proteins |
| 03/10/2005 | WO2005021582A2 Methods for the early diagnosis of ovarian cancer |
| 03/10/2005 | WO2005021574A2 Induction of antiviral neutralizing antibodies in humans and animals |
| 03/10/2005 | WO2005021035A1 A bivalent vaccine against fmd, its preparation methods and applications |
| 03/10/2005 | WO2005021034A2 Safe mutant viral vaccines |
| 03/10/2005 | WO2005021033A2 Vaccine |
| 03/10/2005 | WO2005021032A1 Live attenuated aldolase-negative bacterial vaccine |
| 03/10/2005 | WO2005021031A2 Live attenuated bacterial vaccine |
| 03/10/2005 | WO2005021030A1 Live attenuated leishmania vaccines |
| 03/10/2005 | WO2005021029A2 Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (boris) |
| 03/10/2005 | WO2005020972A2 Combination therapy for the treatment of ocular neovascular disorders |
| 03/10/2005 | WO2005020964A1 Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen |
| 03/10/2005 | WO2005020936A2 Use of lectins to promote oligomerization of glycoproteins and antigenic molecules |